On Wednesday, Hesai Group – ADR (HSAI) stock saw a decline, ending the day at $13.53 which represents a decrease of $-1.23 or -8.33% from the prior close of $14.76. The stock opened at $14.2 and ...
Delhi Election 2025: Election watchdog Association for Democratic Reforms (ADR) released the criminal and financial ...
ADR (BILI) stock saw a decline, ending the day at $16.78 which represents a decrease of $-0.64 or -3.67% from the prior close of $17.42. The stock opened at $17.13 and touched a low of $16.78 during ...
As Delhi approaches its 2025 elections, a staggering 66% of sitting MLAs face criminal charges, with one AAP MLA boasting an ...
Our fair value estimate is $5.20, based on the Jan. 9, 2025, exchange rate of USD 1.03/EUR. Our fair value estimate implies price/earnings and enterprise value/EBITDA multiples of 18 and 9, ...
France's premier video game developer, said on Thursday that there will be a further delay in the release of its highly anticipated title, Assassin's Creed Shadows. The game, which was previously ...
Investors interested in stocks from the Manufacturing - Electronics sector have probably already heard of Powell Industries (POWL) and Kone Oyj Unsponsored ADR (KNYJY). But which of these two stocks ...
Nio is currently posting losses like most other fellow EV companies, but expects its losses to narrow in 2025. It expects 2025 gross margins of 15% and 10%, respectively, for the Nio and Onvo brands.
Subsea 7 S.A. (Oslo Børs: SUBC, ADR: SUBCY) today announced the award of a contract by Equinor for a front-end engineering and design (FEED) study with EPCI1 option for the Fram Sør development ...
Controladora Vuela Compañía de Aviación, S.A.B. de C.V. (NYSE: VLRS and BMV: VOLAR) ("Volaris" or "the Company"), the ultra-low-cost carrier (ULCC) serving ...
Beko continues to garner global recognition for its sustainability initiatives, achieving the first spot on Real Leaders' ...
Drug-induced lung disease cases in France mostly involved ILD, pulmonary edema, and pulmonary fibrosis, largely linked to cancer and CV drugs.